|
INTERCEPT (MALE, 65–69) |
-1.96 |
<0.0001 |
|
ICD-9-CM |
MEMORY LOSS (780.93) |
1.33 |
<0.0001 |
1.02 |
PARALYSIS AGITANS (332.0) |
1.17 |
<0.0001 |
1.01 |
MILD COGNITIVE IMPAIRMENT, SO STATED (331.83) |
1.14 |
<0.0001 |
1.01 |
BIPOLAR DISORDER, UNSPECIFIED (296.80) |
1.00 |
<0.0001 |
1.01 |
UNSPECIFIED PSYCHOSIS (298.9) |
0.44 |
<0.0001 |
1.06 |
LOSS OF WEIGHT (783.21) |
0.42 |
<0.0001 |
1.02 |
DEPRESSIVE DISORDER, NOT ELSEWHERE CLASSIFIED (311) |
0.37 |
<0.0001 |
1.10 |
ALTERED MENTAL STATUS (780.97) |
0.33 |
<0.0001 |
1.16 |
PERSONAL HISTORY OF FALL (V15.88) |
0.32 |
<0.0001 |
1.05 |
OTHER CONVULSIONS (780.39) |
0.32 |
<0.0001 |
1.04 |
UNSPECIFIED FALL (E888.9) |
0.27 |
<0.0001 |
1.06 |
OTHER CHRONIC PAIN (338.29) |
0.28 |
<0.0001 |
1.03 |
ACUTE, BUT ILL-DEFINED, CEREBROVASCULAR DISEASE (436) |
0.24 |
<0.0001 |
1.33 |
URGE INCONTINENCE (788.31) |
0.24 |
<0.0001 |
1.07 |
OTHER ALTERATION OF CONSCIOUSNESS (780.09) |
0.23 |
<0.0001 |
1.09 |
UNSPECIFIED CONSTIPATION (564.00) |
0.21 |
<0.0001 |
1.05 |
UNSPECIFIED URINARY INCONTINENCE (788.30) |
0.21 |
<0.0001 |
1.08 |
ENCOUNTER FOR LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS (V58.69) |
0.17 |
<0.0001 |
1.03 |
LACK OF COORDINATION (781.3) |
0.15 |
<0.0001 |
1.09 |
OTHER MALAISE AND FATIGUE (780.79) |
0.11 |
<0.0001 |
1.15 |
DIABETES MELLITUS (250.02) |
0.12 |
<0.0001 |
1.30 |
ABNORMALITY OF GAIT (781.2) |
0.10 |
<0.0001 |
1.20 |
DIZZINESS AND GIDDINESS (780.4) |
0.11 |
<0.0001 |
1.13 |
UNSPECIFIED CEREBRAL ARTERY OCCLUSION WITH CEREBRAL INFARCTION (434.91) |
0.11 |
0.0083 |
1.35 |
DIABETES MELLITUS (250.00) |
0.07 |
<0.0001 |
1.42 |
EDEMA (782.3) |
0.07 |
<0.0001 |
1.10 |
MUSCLE WEAKNESS (GENERALIZED) (728.87) |
0.06 |
0.0277 |
1.14 |
URINARY TRACT INFECTION, SITE NOT SPECIFIED (599.0) |
0.03 |
0.0526 |
1.12 |
CPT |
SCREENING MAMMOGRAPHY; COMPUTER-AIDED DETECTION (77052) |
-0.25 |
<0.0001 |
1.03 |
COMPUTED TOMOGRAPHY, HEAD OR BRAIN (70450) |
0.16 |
<0.0001 |
1.42 |
RADIOLOGIC EXAMINATION, CHEST; SINGLE VIEW, FRONTAL (71010) |
0.05 |
0.0011 |
1.28 |
Medication (HICL Description) |
VENLAFAXINE HCL |
0.52 |
<0.0001 |
1.02 |
DULOXETINE HCL |
0.45 |
<0.0001 |
1.05 |
TOLTERODINE TARTRATE |
0.32 |
<0.0001 |
1.07 |
SERTRALINE HCL |
0.29 |
<0.0001 |
1.05 |
CITALOPRAM HYDROBROMIDE |
0.25 |
<0.0001 |
1.06 |
POTASSIUM CHLORIDE |
0.24 |
<0.0001 |
1.35 |
OXYBUTYNIN CHLORIDE |
0.22 |
0.0001 |
1.08 |
HYDROCODONE BIT/ACETAMINOPHEN |
0.19 |
<0.0001 |
1.27 |
PROPOXYPHENE/ACETAMINOPHEN |
0.15 |
<0.0001 |
1.09 |
SULFAMETHOXAZOLE/TRIMETHOPRIM |
0.15 |
<0.0001 |
1.12 |
METFORMIN HCL |
0.13 |
0.0001 |
1.40 |
BLOOD SUGAR DIAGNOSTIC |
0.12 |
0.0011 |
1.38 |
LISINOPRIL |
0.11 |
<0.0001 |
1.17 |
CEPHALEXIN MONOHYDRATE |
0.10 |
0.0003 |
1.12 |
SIMVASTATIN |
0.10 |
<0.0001 |
1.17 |
CLOPIDOGREL BISULFATE |
0.09 |
0.0054 |
1.11 |
TRAMADOL HCL |
0.09 |
0.0097 |
1.13 |
GABAPENTIN |
0.07 |
0.0914 |
1.12 |
FUROSEMIDE |
0.00 |
0.9396 |
1.46 |